Related Experiment Video

Updated: Aug 29, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using

Hio Chung Kang1, Il-Jin Kim, Jae-Hyun Park

  • 1Laboratory of Cell Biology, Cancer Research Institute and Cancer Research Center, Seoul National University, Seoul, Korea.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 22, 2004
PubMed
Abstract

Insights

Researchers identified over 250 differentially expressed genes in gastric cancer cells resistant to chemotherapy. Midkine (MDK) was highly overexpressed, suggesting its role in multidrug resistance and offering targets for improved cancer treatment.

Area of Science:

  • Genomics
  • Cancer Biology
  • Pharmacology

Background:

  • Anticancer drug resistance is a significant challenge in chemotherapy, leading to treatment failure.
  • Acquired resistance arises from host factors and genetic or epigenetic alterations in cancer cells.

Purpose of the Study:

  • To identify genes differentially expressed in human gastric cancer cells that are associated with the acquisition of anticancer drug resistance.
  • To understand the molecular mechanisms underlying acquired resistance to chemotherapy in gastric cancer.

Main Methods:

  • Global gene expression analysis was performed on acquired drug-resistant gastric cancer cell lines using Affymetrix HG-U133A microarray.
  • Gene expression patterns of 10 chemoresistant gastric cancer cell lines were compared to four parent cell lines.
  • Statistical analysis included fold-change and Wilcoxon's test to identify differentially expressed genes.

Main Results:

  • Over 250 genes were found to be differentially expressed in gastric cancer cell lines resistant to 5-fluorouracil, cisplatin, or doxorubicin.
  • Eight candidate genes associated with multidrug resistance (resistance to two or more agents) were identified.
  • Midkine (MDK), a heparin-binding growth factor, was significantly overexpressed in all drug-resistant cell lines, indicating a potential role in multidrug resistance.

Conclusions:

  • This study provides a comprehensive dataset of genes associated with acquired drug resistance in gastric cancer.
  • The findings offer a foundation for further functional studies to elucidate the role of identified genes, such as MDK, in gastric cancer drug resistance.
  • Identifying key genes involved in resistance can lead to the development of novel therapeutic strategies to overcome chemotherapy failure.

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...